140 related articles for article (PubMed ID: 35680279)
81. Attainment of Target in Therapeutic Range of International Normalized Ratio and Correlates Among Patients on Warfarin Therapy at Jimma Medical Center, Jimma, Ethiopia.
Jada AU; Disassa GM; Melesse BH; Abafogi MM; Abera EG; Jibicho KH; Tukeni KN
Clin Ther; 2024 Apr; 46(4):354-359. PubMed ID: 38429119
[TBL] [Abstract][Full Text] [Related]
82. Use of oral anticoagulants in complex clinical situations with atrial fibrillation.
Gullón A; Sánchez Fuentes D; López-de-Sá E; Martí-Almor J; Barón-Esquivias G; Jiménez López J; Del Mar Contreras Muruaga M; Suárez Fernández C
Med Clin (Barc); 2018 Jun; 150 Suppl 1():8-24. PubMed ID: 30502871
[TBL] [Abstract][Full Text] [Related]
83. Intracranial subdural hematomas with elevated rivaroxaban concentration and subsequently detected spinal subdural hematoma: A case report.
Yamaguchi Y; Koga M; Matsuki T; Hino T; Yokota C; Toyoda K
Thromb Res; 2016 Jul; 143():127-9. PubMed ID: 27240110
[TBL] [Abstract][Full Text] [Related]
84. Clinical Prediction Model for Time in Therapeutic Range While on Warfarin in Newly Diagnosed Atrial Fibrillation.
Williams BA; Evans MA; Honushefsky AM; Berger PB
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29025746
[TBL] [Abstract][Full Text] [Related]
85. Warfarin in atrial fibrillation patients with moderate chronic kidney disease.
Hart RG; Pearce LA; Asinger RW; Herzog CA
Clin J Am Soc Nephrol; 2011 Nov; 6(11):2599-604. PubMed ID: 21903982
[TBL] [Abstract][Full Text] [Related]
86. South Africa's poor warfarin control raises questions of benefit above other anticoagulant therapies in atrial fibrillation.
Aalbers J
Cardiovasc J Afr; 2011; 22(4):220. PubMed ID: 21881695
[No Abstract] [Full Text] [Related]
87. [A Case of Spontaneous Intracranial Hypotension Successfully Treated with Repetitive Epidural Blood Patch after Warfarin Reversal].
Matsuda T; Matsuzaki K; Satoh K; Ishihara M; Hanaoka M; Niki H; Miyake H
No Shinkei Geka; 2019 Apr; 47(4):441-447. PubMed ID: 31061229
[TBL] [Abstract][Full Text] [Related]
88. Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation.
Pokorney SD; Holmes DN; Thomas L; Fonarow GC; Kowey PR; Reiffel JA; Singer DE; Freeman JV; Gersh BJ; Mahaffey KW; Hylek EM; Naccarelli GV; Ezekowitz MD; Piccini JP; Peterson ED;
JAMA Cardiol; 2019 Aug; 4(8):756-764. PubMed ID: 31268487
[TBL] [Abstract][Full Text] [Related]
89. Anticoagulation for chronic atrial fibrillation.
Stern S; Altkorn D; Levinson W
JAMA; 2000 Jun; 283(22):2901-3. PubMed ID: 10865248
[No Abstract] [Full Text] [Related]
90. Sex Differences in the Management of Oral Anticoagulation and Outcomes for Emergency Department Presentation of Incident Atrial Fibrillation.
Islam S; Dover DC; Daniele P; Hawkins NM; Humphries KH; Kaul P; Sandhu RK
Ann Emerg Med; 2022 Aug; 80(2):97-107. PubMed ID: 35469679
[TBL] [Abstract][Full Text] [Related]
91. Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.
Chan KE; Lazarus JM; Thadhani R; Hakim RM
J Am Soc Nephrol; 2009 Oct; 20(10):2223-33. PubMed ID: 19713308
[TBL] [Abstract][Full Text] [Related]
92. Is the HAS-BLED score useful in predicting post-extraction bleeding in patients taking warfarin? A retrospective cohort study.
Kataoka T; Hoshi K; Ando T
BMJ Open; 2016 Mar; 6(3):e010471. PubMed ID: 26936909
[TBL] [Abstract][Full Text] [Related]
93. Rivaroxaban in atrial fibrillation.
Giorgi MA; Miguel LS
Vasc Health Risk Manag; 2012; 8():525-31. PubMed ID: 22973107
[TBL] [Abstract][Full Text] [Related]
94. Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation.
Weitz JI; Connolly SJ; Patel I; Salazar D; Rohatagi S; Mendell J; Kastrissios H; Jin J; Kunitada S
Thromb Haemost; 2010 Sep; 104(3):633-41. PubMed ID: 20694273
[TBL] [Abstract][Full Text] [Related]
95. Barriers to the use of warfarin: potential solutions.
McAnulty JH
J Interv Card Electrophysiol; 2004; 10 Suppl 1():17-20. PubMed ID: 14739735
[No Abstract] [Full Text] [Related]
96. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.
Fang MC; Chang Y; Hylek EM; Rosand J; Greenberg SM; Go AS; Singer DE
Ann Intern Med; 2004 Nov; 141(10):745-52. PubMed ID: 15545674
[TBL] [Abstract][Full Text] [Related]
97. Clinical inquiries. Does combining aspirin and warfarin decrease the risk of stroke for patients with nonvalvular atrial fibrillation?
Robertson SL; Mayer JB; Guthmann R
J Fam Pract; 2004 Jul; 53(7):570-5. PubMed ID: 15251100
[No Abstract] [Full Text] [Related]
98. Anticoagulation intensity for elderly atrial fibrillation patients: should we use a conventional INR target (2.0 to 3.0) or a lower range?
Lane DA; Lip GY
Thromb Haemost; 2010 Feb; 103(2):254-6. PubMed ID: 20076858
[No Abstract] [Full Text] [Related]
99. Risk of ischemic stroke and hemorrhagic complications in warfarinized patients with non-valvular atrial fibrillation.
Uchiyama S
Intern Med; 2001 Dec; 40(12):1166-7. PubMed ID: 11813834
[No Abstract] [Full Text] [Related]
100. Home monitoring of warfarin effects.
Lippi G; Franchini M
N Engl J Med; 2011 Jan; 364(4):378; author reply 378-9. PubMed ID: 21268733
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
